RK

Rajesh Kamalakant Tiwari

Active Director Director DIN 09010859
DIN 09010859 First appointment Dec 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Rajesh Kamalakant Tiwari

Data last updated:

Rajesh Kamalakant Tiwari is a Director at Lezire Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Lezire Pharmaceuticals Private Limited reported revenue of ₹6.3 Lakh (FY 2019).

DIN 09010859
Primary Designation Director
Industry Trading
First Appointment 26 Dec 2020
Oldest Company Age 9 yrs
Largest company Lezire Pharmaceuticals Private Limited · ₹6.3 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Dec 20202017₹6.3 Lakh (FY 2019)Active

Board colleagues of Rajesh Kamalakant Tiwari

Directorship timeline

Open interactive timeline →
Lezire Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Kamalakant Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kamalakant Tiwari

Rajesh Kamalakant Tiwari currently holds 1 directorship: Lezire Pharmaceuticals Private Limited (Director, since 26 Dec 2020, revenue ₹6.3 Lakh (FY 2019)).

Rajesh Kamalakant Tiwari was first appointed on 26 Dec 2020 as Director at Lezire Pharmaceuticals Private Limited.

The current boards of Rajesh Kamalakant Tiwari's companies include Shivnarayan Shivpujan Ram (Lezire Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available